Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indazole derivatives useful as CB-1 inverse agonists

Indazole derivatives useful as CB-1 inverse agonists

US Patent 9682940 · Granted Jun 20, 2017

Estimated economic value: $117,780,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
MEK inhibitors and therapeutic uses thereof2025
CD19-based chimeric antigen receptor and application thereof2025
5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a fac2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025
Immunoglobulins and uses thereof2024
Immunoglobulins and uses thereof2024
Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024
Pyridine N-oxide derivatives useful as factor XIa inhibitors2023
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine t2023